Helius is a leading neurotechnology company in the medical device field, specializing in utilizing non-implantable platform technologies to treat neurological deficits, enhance the brain's compensatory abilities, and promote neuroplasticity, thereby improving the lives of patients with neurological disorders. The company has announced the establishment of the SOL Treasury.